These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9386326)

  • 21. Anthrax toxins and the host: a story of intimacy.
    Mock M; Mignot T
    Cell Microbiol; 2003 Jan; 5(1):15-23. PubMed ID: 12542467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthrax toxins: A paradigm of bacterial immune suppression.
    Baldari CT; Tonello F; Paccani SR; Montecucco C
    Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
    Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raxibacumab.
    Mazumdar S
    MAbs; 2009; 1(6):531-8. PubMed ID: 20068396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemical basis of the virulence of Bacillus anthracis. VII. Two components of the anthrax toxin: their relationship to known immunising aggressins.
    SMITH H; TEMPEST DW; STANLEY JL; HARRIS-SMITH PW; GALLOP RC
    Br J Exp Pathol; 1956 Jun; 37(3):263-71. PubMed ID: 13342351
    [No Abstract]   [Full Text] [Related]  

  • 27. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New clue to how anthrax kills.
    Strauss E
    Science; 1998 May; 280(5364):676. PubMed ID: 9599144
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
    Xu Q; Hesek ED; Zeng M
    Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.
    Bozue J; Cote CK; Moody KL; Welkos SL
    Infect Immun; 2007 Jan; 75(1):508-11. PubMed ID: 17074844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the pagR gene of pXO2 in anthrax pathogenesis.
    Liang X; Zhang E; Zhang H; Wei J; Li W; Zhu J; Wang B; Dong S
    Sci Rep; 2016 Jul; 6():28827. PubMed ID: 27363681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anthrax toxin dynamics in the body].
    Golubinskiĭ EP; Tafel'shteĭn EE; Kolesnik VS; Osipenko II; Kondrat'eva AM
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):98-100. PubMed ID: 2472713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
    Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.